Nisa Investment Advisors
NAGE

Nisa Investment Advisors’s Niagen Bioscience NAGE Stock Holding History

Nisa Investment Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21K Hold
379
– – ﹤0.01% 2825
2026
Q1 		$1.67K Sell
379
-94
-20% -$508 ﹤0.01% 2651
2025
Q4 		$3.01K Sell
473
-547
-54% -$3.81K ﹤0.01% 2542
2025
Q3 		$9.52K Hold
1,020
– – ﹤0.01% 2297
2025
Q2 		$14.7K Buy
1,020
+547
+116% +$5.4K ﹤0.01% 2084
2025
Q1 		$3.26K Buy
473
+94
+25% +$591 ﹤0.01% 2350
2024
Q4 		$2.01K Sell
379
-29
-7% -$159 ﹤0.01% 2486
2024
Q3 		$1.49K Buy
+408
New +$1.28K ﹤0.01% 2479
2020
Q4 		– Sell
-14,741
Closed -$59K – 2367
2020
Q3 		$59K Buy
+14,741
New +$71.1K ﹤0.01% 1736

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nisa Investment Advisors's NAGE Position: Q2 2026 in Review

Nisa Investment Advisors held its Niagen Bioscience (NAGE) position steady in Q2 2026 at 379 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2825.

Nisa Investment Advisors first reported a position in NAGE in Q3 2020 and has held it in 9 quarters since. The position peaked at $59K in Q3 2020. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Nisa Investment Advisors held 379 shares of Niagen Bioscience worth $1.21K as of Q2 2026.
  • Nisa Investment Advisors left its Niagen Bioscience share count unchanged in Q2 2026.
  • Niagen Bioscience made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2825 holding.
  • Nisa Investment Advisors first reported a position in Niagen Bioscience in Q3 2020 and has held it in 9 quarters since.
  • Nisa Investment Advisors's Niagen Bioscience position peaked at $59K in Q3 2020.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.